L-carnitine fumarate and isovaleryl-L-carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice

Calcified Tissue International

Volumn 82, Issue 3, 2008, Pages 221-228

  Patano, N ^a   Mancini, L ^a   Settanni, M P ^a   Strippoli, M ^a   Brunetti, G ^a   Greco, G ^a   Tamma, R ^a   Vergari, R ^a   Sardelli, F ^b   Koverech, A ^b   Colucci, S ^a   Zallone, A ^a   Grano, M ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Carnitine Research and Development Department   (Italy)

Author keywords

Bone histomorphometry; Carnitine; Carnitine derivative; Osteoporosis

Indexed keywords

CARNITINE DERIVATIVE; ISOVALERYL LEVO CARNITINE FUMARATE; LEVO CARNITINE FUMARATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MASS; BONE REMODELING; BONE STRUCTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; LUMBAR VERTEBRA; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PERIMETRY; PREGNANCY; PRIORITY JOURNAL; TRABECULAR BONE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CALCIUM, DIETARY; CARNITINE; CELL COUNT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; LUMBAR VERTEBRAE; MICE; MICE, INBRED STRAINS; OSTEOBLASTS; OSTEOPOROSIS; PREGNANCY;

EID: 41049087389     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9109-6     Document Type: Article

References (27)

1. Borum PR (1980) Regulation of carnitine concentration in plasma. In: Frenkel RA, McGarry JD (eds) Carnitine biosynthesis, metabolism and functions. Academic Press, New York, pp 115-126
2. Evangeliou A, Vlassopoulos D (2003) Carnitine metabolism and deficit-when is supplementation necessary? Curr Pharm Biotechnol 4:211-219
3. Maccari F, Arseni A, Chiodi P, Ramacci MT, Angelucci L (1990) Levels of carnitines in brain and other tissues of rats of different ages: effect of acetylitine administration. Exp Gerontol 25:127-134
4. Costell M, O'Connor JE, Grisolia S (1989) Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun 161:1135-1143
5. Costell M, Grisolia S (1993) Effect of carnitine feeding on the levels of heart and skeletal muscle carnitine of elderly mice. FEBS Lett 315:43-46
6. Adamek G, Felix R, Guenther HL, Fleisch H (1987) Fatty acid oxidation in bone tissue and bone cells in culture. Biochem J 242:129-137
7. Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, Simone GM, Sardelli F, Koverech A, Zallone A, Grano M (2005) l-Carnitine and isovaleryl l-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int 76:458-465
8. Chiu KM, Keller ET, Crenshaw TD, Gravenstein S (1999) Carnitine and dehydroepiandrosterone sulphate induced protein synthesis in porcine osteoblast-like cells. Calcif Tissue Int 64:527-533
9. Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20:177-184
10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
11. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F (2001) Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 86:3579-3594
12. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
13. Salomon CD, Volpin G (1970) Fine structure of bone resorption in experimental osteoporosis caused by calcium deficient diet in rats. An electron microscopic study of compact bone. Calcif Tissue Res 4:80-82
14. Ornoy A, Wolinsky I, Guggenheim K (1974) Structure of long bones of rats and mice fed a low calcium diet. Calcif Tissue Res 15:71-76
15. Shen V, Birchman R, Xu R, Lindsay R, Dempster DW (1995) Short term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium-deficient rats. Bone 16:149-156
16. Kunkel ME, Powers DL, Hord NG (1990) Comparison of chemical, histomorphometric, and absorptiometric analyses of bones of growing rats subjected to dietary calcium stress. J Am Coll Nutr 9:633-640
17. Thomas ML, Simmons DJ, Kidder L, Ibarra MJ (1991) Calcium metabolism and bone mineralization in female rats fed diets marginally sufficient in calcium: effects of increased dietary calcium intake. Bone Miner 12:1-14
18. Weinreb M, Rodan GA, Thompson DD (1991) Immobilization related bone loss in the rat is increased by calcium deficiency. Calcif Tissue Int 48:93-100
19. Shen V, Birchman R, Xu R, Lindsay R, Dempster DW (1995) Short term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium-deficient rats. Bone 16:149-156
20. Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832-872
21. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J (1992) Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267:12692-12699
22. Ernst M, Rodan GA (1990) Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814
23. Conover CA, Kiefer MC (1993) Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159
24. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F (2001) Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol Metab 86:3579-3594
25. Benvenga S, Amato A, Calvani M, Trimarchi F (2004) Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci 1033:158-167
26. Sener G, Eksioglu-Demiralp E, Cetiner M, Ercan F, Sirvanci S, Gedik N, Yegen BC (2006) l-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol 2006:47-60
27. Abd-Allah AR, Al-Majed AA, Al-Yahya AA, Fouda SI, Al-Shabana OA (2005) l-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC). Arch Toxicol 79:406-413